<div id="readability-page-1">Kura Oncology, Inc. (NASDAQ:KURA) is one of the stocks Jim Cramer offered insights on. When a caller highlighted the company’s $135 million milestone payment owing to its U.S. commercial sale of KOMZIFTI, Cramer commented: “That’s a lot. That is a lot… Now, just understand that, yeah, they are milestone payments, not actual. Now, here’s what […]</div>

KURA

<p>吉姆·克莱默讨论了 Kura Oncology（NASDAQ:KURA）作为一种投机性投资。他提到该公司因 KOMZIFTI 在美国的商业销售获得了 1.35 亿美元的里程碑付款，强调这些是里程碑付款，而非实际收益</p>

Jim Cramer 将 Kura Oncology 视为一个投机性投资进行讨论